Imatinib vs Montelukast
Imatinib vs Montelukast: Overview
This comparison examines the pharmacological differences between Imatinib and Montelukast.
Mechanism of Action
Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.
Montelukast: Selective leukotriene D4 receptor antagonist.
Pharmacokinetics
Half-life: Imatinib — 18 hours; Montelukast — 2.7-5.5 hours.
Chemical Properties
Molecular Formula: Imatinib — C29H31N7O; Montelukast — C35H36ClNO3S.
Molecular Weight: Imatinib — 493.6030 g/mol; Montelukast — 586.1800 g/mol.
Type: Imatinib — Small molecule; Montelukast — Small molecule.